GM Watch
  • Main Menu
    • Home
    • News
      • Newsletter subscription
      • News Reviews
      • News Languages
        • Notícias em Português
        • Nieuws in het Nederlands
        • Nachrichten in Deutsch
      • Archive
    • Resources
      • GM Myth Makers
      • Gene Editing
      • Non-GM successes
      • GM Quotes
      • GM Myths
      • GM Firms
        • Monsanto: a history
        • Monsanto: resources
        • Bayer: a history
        • Bayer: resources
      • GM Booklet
      • GM Book
    • Contact
    • About
    • Search
    • Donations
News and comment on genetically modified foods and their associated pesticides    
  • News
    • Newsletter subscription
    • News Reviews
    • News Languages
      • Notícias em Português
      • Nieuws in het Nederlands
      • Nachrichten in Deutsch
    • Archive
  • Resources
    • Non-GM Successes
    • GM Myth Makers
    • Gene Editing
    • GM Quotes
    • GM Myths
    • GM Firms
      • Monsanto: a history
      • Monsanto: resources
      • Bayer: a history
      • Bayer: resources
    • GM Booklet
    • GM Book
  • Donations
  • Contact
  • About
  • Search

INTRODUCTION TO GM

GMO Myths and Facts front page.jpg

GENE EDITING MYTHS, RISKS, & RESOURCES

Gene Editing Myths and Reality

Bayer's Headache: So much for keeping this quiet

  • Print
  • Email
Details
Published: 12 March 2003
Twitter

12 March 2003

BAYER’S HEADACHE: SO MUCH FOR KEEPING THIS QUIET

from PR WATCH's 'the weekly spin' about the key company in relation to GM crop releases in the UK:

BAYER'S HEADACHE
http://abcnews.go.com/wire/Living/ap20030307_1457.html

A $100 million lawsuit against Bayer Corp. has yielded e-mails and internal documents that suggest the drug company let marketing and PR concerns trump safety, disregarding disturbing research on the cholesterol drug Baycol before it was pulled off the market because of dozens of deaths. "There have been some deaths related to Baycol. ... So much for keeping this quiet," said one E-mail.

Another message wondered, "How will marketing spin this?" Other documents show that Bayer executives worried about studying possible side effects of the drug because any results would have to be reported to the FDA.

SOURCE: Associated Press, March 7, 2003
More web links related to this story are available at:
http://www.prwatch.org/spin/March_2003.html#1047013201

Menu

Home

Subscriptions

News Archive

News Reviews

GM Book

Resources

Non-GM Successes

GM Myth Makers

GM Myths

GM Quotes

GM Booklet

Contacts

Contact Us

About

Facebook

Twitter

Donations

Content 1999 - 2025 GMWatch.
Web Development By SCS Web Design